Mangoceuticals, Inc. (MGRX) Stock Statistics & Valuation Metrics

Mangoceuticals, Inc. has a market cap or net worth of $20.44M. The enterprise value is $1.04B.

Mangoceuticals, Inc. has 10,644,458 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mangoceuticals, Inc.’s return on equity (ROE) is -0.62 and return on invested capital (ROIC) is -56.04%.

The current PE Ratio of Mangoceuticals, Inc. is -0.55. Mangoceuticals, Inc.’s PEG ratio is 0.00.

In the last 12 months, Mangoceuticals, Inc. had revenue of 615.87K and earned -8.71M in profits. Earnings per share was -4.84.

In the last 12 months, operating cash flow was -3.87M and capital expenditures 0.00, giving a free cash flow of -3.87M billion.

Mangoceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Mangoceuticals, Inc. upcoming earnings date is ―, TBA Not Confirmed.

Mangoceuticals, Inc. as a current ratio of 0.05, with Debt / Equity ratio of -234.87%

In the past 12 months, Mangoceuticals, Inc. has paid 0.00 in taxes.

Mangoceuticals, Inc. EV to EBITDA ratio is -0.62, with an EV/FCF ratio of -1.02.

Mangoceuticals, Inc. has $76.50K in cash and marketable securities with $47.71K in debt, giving a net cash position of -$28.78K billion.

Gross margin is 0.00%, with operating margin of -1684.48%, and net profit margin of -1839.61%.

The average price target for Mangoceuticals, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―